Skip to main content
Jeffrey Popma, MD, Cardiology, Boston, MA

Jeffrey Popma MD

Adult Congenital Heart Disease, Interventional Cardiology


Professor, Medicine-Beth Israel Deaconess Medical Center, Harvard Medical School

Join to view full profile
  • 185 Pilgrim Rd# BAKER4Boston, MA 02215

  • Phone+1 617-632-9210

  • Fax+1 617-632-7460

Dr. Popma is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Michigan
    University of MichiganFellowship, Cardiovascular Disease, 1989 - 1990
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1986 - 1989
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1982 - 1986
  • University of California (San Francisco)/Fresno
    University of California (San Francisco)/FresnoInternship, Transitional Year, 1981 - 1982
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 1981

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1998 - 2027
  • MD State Medical License
    MD State Medical License 1991 - 1999
  • DC State Medical License
    DC State Medical License 1991 - 1998
  • MI State Medical License
    MI State Medical License 1989 - 1993
  • TX State Medical License
    TX State Medical License 1983 - 1989
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Quality Data Center, Massachusetts eHealth Collaborative (MAeHC), 2012-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012-2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Transcatheter Aortic Valve Replacement in Low-Risk Patients with Bicuspid Aortic Valve Stenosis  
    John K Forrest, Basel Ramlawi, Neal S Kleiman, Stanley J Chetcuti, Hector I Michelena, Jeffrey A Skiles, Jeffrey J Popma, Michael J Reardon, JAMA Cardiology
  • Original Research Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Low-Gradient Aortic Stenosis  
    Harold L Dauerman, Jon R Resar, Steven J Yakubov, P Michael Grossman, Stanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, Jae K Oh, ScienceDirect
  • Original Investigation Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients  
    Jeffrey J Popma, Thomas G Gleason, William H Ryan, Neal S Kleiman, Tanvir Bajwa, David L Brown, ScienceDirect

Lectures

  • Protected PCI: A Contemporary Look at Clinical Data from cVAD 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
  • Large-Hole Transfemoral Closure I: The PerQseal Device 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
  • Acquiring Advanced - Complication Management 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019

Press Mentions

  • MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed
    MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDedJuly 3rd, 2025
  • Positive Results with Carillon Mitral Device Seen in Real-World Registries
    Positive Results with Carillon Mitral Device Seen in Real-World RegistriesFebruary 21st, 2025
  • Three-Year Data Presented from Medtronic Evolut Low Risk Trial of TAVR Versus SAVR
    Three-Year Data Presented from Medtronic Evolut Low Risk Trial of TAVR Versus SAVRMarch 5th, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: